BIOBUILDS Competitors

SNC is a trusted global leader in aerospace and national security. Our innovative solutions enable connected protection through command, control and communications systems, as well as ISR, cyber, electromagnetic spectrum management, and other high capabilities for systems across all domains – sea, land, air, space and cyber. As a longstanding leader in defense technology, SNC is the optimum intersection of commercial, defense and non-traditional contractors. We are one of the only privately owned mid-tier A&D contractors and we pride ourselves on our ability to invest early and often to ensure mission success on or ahead of schedule. It’s part of our mission to always stay one step ahead; working on solutions today to solve the problems of tomorrow. Founded in 1963, SNC is owned by Chairwoman Eren Ozmen and CEO Fatih Ozmen.

Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits. In December 2022, Novozymes and Chr. Hansen entered into an agreement to create a leading global biosolutions partner by combining the two companies. The goal was to unleash the full potential of biosolutions and generate significant value for all stakeholders and society. The combination was completed on January 29, 2024 and Novonesis was born. The name means ‘a new beginning’ and is derived from the Greek word ‘genesis’. It reflects a new era where we’ll better our world with biology. You can find Novonesis on LinkedIn here: linkedin.com/company/novonesis. Novozymes A/S, part of Novonesis Group.

bluebird bio has rebranded as Genetix Biotherapeutics, returning to our foundational roots and renewing our commitment to delivering transformative genetic therapies for patients living with sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. Follow our new page at the link below!